Vaccine for inducing an improved immune reaction
AssigneeEyegene, Inc.
InventorsYang Je Cho, Na Gyong Lee, Jin Wook Jang, Kwang Sung Kim, Won Il Yoo
Life of this patent
Estimating the term…
Loading patent…
AssigneeEyegene, Inc.
InventorsYang Je Cho, Na Gyong Lee, Jin Wook Jang, Kwang Sung Kim, Won Il Yoo
Estimating the term…
The present invention relates to a pharmaceutical vaccine composition comprising: (a) a pathogen-derived antigen selected from the group consisting of Mycobacterium tuberculosis antigen, Bacillus anthracis antigen, HAV (hepatitis A virus) antigen, HBV (hepatitis B virus) antigen, HCV (hepatitis C virus) antigen, HIV (human immunodeficiency virus) antigen, influenza virus antigen, HSV (herpes simplex virus) antigen, Hib (Haemophilus influenzae type b) antigen, Neisseria meningitidis antigen, Corynebacterium diphtheriae antigen, Bordetella pertussis antigen, Clostridium tetani antigen and Varicella virus antigen; (b) a deacylated non-toxic LOS (lipooligosaccharide); and (c) a pharmaceutically acceptable carrier.
1-34. (canceled)
A method for inducing immunity to an antigen in a subject, the method comprising:
A method for preparing maturated dendritic cells, comprising incubating immatured dendritic cells with a deacylated non-toxic LOS (Lipooligosaccharide).
Dependencies are inferred from the claim text.